Bio Green Med Solution, Inc. SEC filings BGMS

Bio Green Med Solution, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Mar 31, 2010. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (listing notice). The company's fiscal year ends on December 31.

Bio Green Med Solution, Inc. SEC filings
Form Description Filed Period
10-K Annual report Mar 30, 2026 Dec 31, 2025
10-K/A Amended annual report Nov 26, 2025 Dec 31, 2024
10-K Annual report Apr 2, 2025 Dec 31, 2024
ARS Annual report to shareholders May 8, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 21, 2024 Dec 31, 2023
10-K/A Amended annual report Nov 29, 2023 Dec 31, 2022
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Mar 8, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
10-K Annual report Mar 5, 2020 Dec 31, 2019
10-K Annual report Mar 28, 2019 Dec 31, 2018
10-K Annual report Mar 30, 2018 Dec 31, 2017
10-K Annual report Mar 31, 2017 Dec 31, 2016
10-K Annual report Mar 29, 2016 Dec 31, 2015
ARS Annual report to shareholders Apr 24, 2015 Dec 31, 2014
10-K Annual report Mar 31, 2015 Dec 31, 2014
ARS Annual report to shareholders May 15, 2014 Dec 31, 2013
10-K Annual report Mar 26, 2014 Dec 31, 2013
ARS Annual report to shareholders Apr 24, 2013 Dec 31, 2012
10-K Annual report Apr 1, 2013 Dec 31, 2012
ARS Annual report to shareholders May 2, 2012 Dec 31, 2011
10-K Annual report Mar 30, 2012 Dec 31, 2011
ARS Annual report to shareholders May 9, 2011 Dec 31, 2010
10-K Annual report Mar 31, 2011 Dec 31, 2010
ARS Annual report to shareholders Jun 14, 2010 Dec 31, 2009
10-K/A Amended annual report May 19, 2010 Dec 31, 2009
10-K/A Amended annual report May 17, 2010 Dec 31, 2009

Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Wholesale-Durable Goods, NEC (SIC 5099)
Listed as
BGMS (Nasdaq), BGMSP (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Berkeley Heights, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1130166
Former names
Cyclacel Pharmaceuticals, Inc. (until Sep 12, 2025); XCYTE THERAPIES INC (until Mar 24, 2006)

Other Wholesale-Durable Goods, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.